Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Divigel?

See the DrugPatentWatch profile for Divigel

Divigel is a brand-name topical estrogen product. It contains estradiol (a form of estrogen) and is used as hormone replacement therapy for postmenopausal symptoms (like hot flashes and vaginal dryness) and for osteoporosis risk reduction in some cases.

If you’re asking about getting or using Divigel, here are the basics:

- How it’s used: Divigel is a transdermal gel applied to the skin. It’s typically used once daily on a clean, dry area of the skin (often the lower abdomen or upper thigh), and you should rotate application sites. After applying, let it dry and wash your hands. Do not apply to the breasts, face, or irritated skin.

- Important considerations:
- It’s a prescription medicine. Your doctor chooses the dose and treatment duration based on your symptoms and medical history.
- It may interact with other medicines (check with your clinician if you’re taking blood thinners, anticonvulsants, rifampin, St. John’s wort, or certain other drugs).
- It should not be used during pregnancy. If pregnancy is possible, tell your doctor.
- It can increase the risk of blood clots, stroke, heart attack, gallbladder disease, and certain cancers with long-term use. The benefits and risks should be weighed, especially if you have risk factors.

- Side effects (common): breast tenderness, nausea, headaches, vaginal bleeding or spotting, skin irritation at the application site.

- When to contact a clinician: unusual vaginal bleeding, chest pain, severe headache, leg swelling, shortness of breath, severe skin reaction at the application site, or if you develop symptoms suggestive of a blood clot.

If you’d like, tell me what you want to know specifically:
- Are you considering using Divigel or have it prescribed already?
- Do you want dosing details, potential interactions, or a comparison with other menopausal therapies?
- Do you have any medical conditions or other medicines I should consider when discussing Divigel?



Other Questions About Divigel :

Cost of divigel? Generic divigel? Goodrx divigel 0 5 mg price? Goodrx divigel price? Goodrx divigel 1 mg price? Divigel coupon? Goodrx divigel price 1 mg packet 30?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Aligned

Patient Risk: Low

Summary

The AI claim matches the label’s Warning (5.2) stating increased endometrial cancer risk with unopposed estrogen in women with a uterus, including the reported relative risk range and dependence on duration/dose, and is consistent with the label’s statement that adding a progestogen reduces risk.


Category Scores

Warnings
100
Excellent

Accurate Statements

Unopposed estrogen in women with a uterus increases endometrial cancer risk.
Section 5.2 — Malignant Neoplasms (Endometrial Cancer): “An increased risk of endometrial cancer has been reported with the use of unopposed estrogen therapy in a woman with a uterus.”
The reported endometrial cancer risk among unopposed estrogen users is about 2 to 12 times greater than in non-users and appears dependent on duration of treatment and on estrogen dose.
Section 5.2 — Malignant Neoplasms (Endometrial Cancer): “about 2 to 12 times greater… appears dependent on duration… and on estrogen dose.”
Adding a progestogen to estrogen-alone therapy reduces endometrial cancer risk by reducing endometrial hyperplasia.
Section 5.2 — Malignant Neoplasms (Endometrial Cancer): “Adding a progestogen to estrogen-alone therapy has been shown to reduce the risk of endometrial hyperplasia…”; and Section 2.1 — Important Use Information: progestogen reduces endometrial cancer risk.

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The evaluated statement(s) accurately reflect label warning information about endometrial cancer risk with unopposed estrogen in women with a uterus and the risk-reduction rationale for adding a progestogen.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Aligned

Primary Issue

Suggested Improvement